Sub menu

 
 

GARDASIL Quadrivalent Human Papillomavirus (types 6,11,16,18) Recombinant Vaccine, 20-40-40-20 mcg/0.5mL sterile liquid syringe- export only Cancelled under s30(1)(c) of the Act

Product name
GARDASIL Quadrivalent Human Papillomavirus (types 6,11,16,18) Recombinant Vaccine, 20-40-40-20 mcg/0.5mL sterile liquid syringe- export only
Sponsor
Merck Sharp & Dohme Australia Pty Ltd
ARTG
129658
Date of effect
Decision type
Cancelled under s30(1)(c) of the Act

Help us improve the Therapeutic Goods Administration site